{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T09:16:21Z","timestamp":1795252581202,"version":"4.10.3"},"reference-count":66,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T00:00:00Z","timestamp":1647734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The current study investigated the cytotoxic effect of ten sulfonamide-derived isatins, following molecular hybridization, based on the association principles, on hepatocellular carcinoma (HCC) HepG2 and Huh7 cell lines, compared for safety using human normal retina pigmented epithelial (RPE-1) cells. The ten compounds showed variable in vitro cytotoxicity on HepG2 and Huh7 cells, using the MTT assay. Four compounds (4\/10) were highly cytotoxic to both HepG2 and HuH7. However, only 3 of these 4 were of the highest safety margin on RPE-1 cells in vitro and in the in vivo acute (14-day) oral toxicity study. These later, superior three compounds\u2019 structures are 3-hydroxy-3-(2-oxo-2-(p-tolyl)ethyl)-5-(piperidin-1-ylsulfonyl)indolin-2-one (3a), N-(4-(2-(2-oxo-5-(piperidin-1-ylsulfonyl)indolin-3-ylidene)acetyl)phenyl)acetamide (4b), and N-(3-(2-(2-oxo-5-(piperidin-1-ylsulfonyl)indolin-3-ylidene)acetyl)phenyl)acetamide (4c). The half-maximal inhibitory concentration (IC50) of the tested compounds (3a, 4b, and 4c) on HepG2 cells were approximately 16.8, 44.7, and 39.7 \u03bcM, respectively. The 3a, 4b, and 4c compounds significantly decreased the angiogenic marker epithelial growth factor receptor (EGFR) level and that was further confirmed via molecular docking inside the EFGR active site (PDB: 1M17). The binding free energies ranged between \u221219.21 and \u221221.74 Kcal\/mol compared to Erlotinib (\u221225.65 Kcal\/mol). The most promising compounds, 3a, 4b, and 4c, showed variable anticancer potential on \u201challmarks of cancer\u201d, significant cytotoxicity, and apoptotic anti-angiogenic and anti-invasive effects, manifested as suppression of Bcl-2, urokinase plasminogen activation, and heparanase expression in HepG2-treated cells\u2019 lysate, compared to non-treated HepG2 cells. In conclusion, compound \u201c3a\u201d is highly comparable to doxorubicin regarding cell cycle arrest at G2\/M, the pre-G0 phases and early and late apoptosis induction and is comparable to Erlotinib regarding binding to EGFR active site. Therefore, the current study could suggest that compound \u201c3a\u201d is, hopefully, the most safe and active synthesized isatin sulfonamide derivative for HCC management.<\/jats:p>","DOI":"10.3390\/biomedicines10030722","type":"journal-article","created":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T21:25:00Z","timestamp":1647811500000},"page":"722","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Anticancer Effects with Molecular Docking Confirmation of Newly Synthesized Isatin Sulfonamide Molecular Hybrid Derivatives against Hepatic Cancer Cell Lines"],"prefix":"10.3390","volume":"10","author":[{"given":"Mahmoud","family":"Eldeeb","sequence":"first","affiliation":[{"name":"Department of Biochemistry, Biotechnology Research Institute, National Research Centre, 12622 Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5406-2029","authenticated-orcid":false,"given":"Eman F.","family":"Sanad","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Ain Shams University, 11566 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8542-7465","authenticated-orcid":false,"given":"Ahmed","family":"Ragab","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science (for Boys, Cairo Branch), Al-Azhar University, 11884 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousry A.","family":"Ammar","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Faculty of Science (for Boys, Cairo Branch), Al-Azhar University, 11884 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Pharmaceutical and Drug Industries Research Institute, National Research Centre, 12622 Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh M.","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Biotechnology Research Institute, National Research Centre, 12622 Giza, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2105-107X","authenticated-orcid":false,"given":"Nadia M.","family":"Hamdy","sequence":"additional","affiliation":[{"name":"Biochemistry and Molecular Biology Department, Faculty of Pharmacy, Ain Shams University, 11566 Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Tsuchiya, K. (2021). Switching from Apoptosis to Pyroptosis: Gasdermin-Elicited Inflammation and Antitumor Immunity. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010426"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.7324\/JAPS.2019.91209","article-title":"Chemotherapeutic effect of Ulmus pumila leaves methanolic extract against N-methyl-N-nitrosourea-induced mammary carcinoma in female rats: An in vitro and in vivo study","volume":"9","author":"Hussien","year":"2019","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-019-1029-8","article-title":"The role of necroptosis in cancer biology and therapy","volume":"18","author":"Gong","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1016\/j.bmcl.2015.08.041","article-title":"Discovery of novel isatin\u2013dehydroepiandrosterone conjugates as potential anticancer agents","volume":"25","author":"Ke","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejmech.2014.01.015","article-title":"N-Propargylated isatin-Mannich mono-and bis-adducts: Synthesis and preliminary analysis of in vitro activity against Tritrichomonas foetus","volume":"74","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1016\/j.bmcl.2013.03.099","article-title":"Synthesis and antiproliferative evaluation of piperazine-1-carbothiohydrazide derivatives of indolin-2-one","volume":"23","author":"Lin","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1039\/C2MD20249B","article-title":"A new class of fluorinated 5-pyrrolidinylsulfonyl isatin caspase inhibitors for PET imaging of apoptosis","volume":"4","author":"Howell","year":"2013","journal-title":"MedChemComm"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"103619","DOI":"10.1016\/j.bioorg.2020.103619","article-title":"Design, synthesis, in vitro antimicrobial evaluation and molecular docking studies of indol-2-one tagged with morpholinosulfonyl moiety as DNA gyrase inhibitors","volume":"96","author":"Salem","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"128900","DOI":"10.1016\/j.molstruc.2020.128900","article-title":"Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship","volume":"1222","author":"Nath","year":"2020","journal-title":"J. Mol. Struct."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejmech.2017.12.043","article-title":"Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds","volume":"144","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s41061-019-0240-9","article-title":"Systematic review on cytotoxic and anticancer potential of n-substituted isatins as novel class of compounds useful in multidrug-resistant cancer therapy: In silico and in vitro analysis","volume":"377","author":"Gupta","year":"2019","journal-title":"Top. Curr. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/1940-6207.CAPR-10-0354","article-title":"Zerumbone induces heme oxygenase-1 expression in mouse skin and cultured murine epidermal cells through activation of Nrf2","volume":"4","author":"Shin","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ejmech.2015.07.004","article-title":"Incorporation of a Michael acceptor enhances the antitumor activity of triterpenoic acids","volume":"101","author":"Heller","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ejmech.2016.08.039","article-title":"Hybrid molecules: The privileged scaffolds for various pharmaceuticals","volume":"124","author":"Mishra","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1021\/jm901616h","article-title":"Hybrid molecules from xanomeline and tacrine: Enhanced tacrine actions on cholinesterases and muscarinic M1 receptors","volume":"53","author":"Fang","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2147\/DDDT.S140164","article-title":"Isatin-benzoazine molecular hybrids as potential antiproliferative agents: Synthesis and in vitro pharmacological profiling","volume":"11","author":"Eldehna","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1900367","DOI":"10.1002\/ardp.201900367","article-title":"Recent advances in isatin hybrids as potential anticancer agents","volume":"353","author":"Ding","year":"2020","journal-title":"Arch. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/biof.1408","article-title":"Isatin, an endogenous nonpeptide biofactor: A review of its molecular targets, mechanisms of actions, and their biomedical implications","volume":"44","author":"Medvedev","year":"2018","journal-title":"BioFactors"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1039\/C8MD00585K","article-title":"Isatin and its derivatives: A survey of recent syntheses, reactions, and applications","volume":"10","author":"Varun","year":"2019","journal-title":"Medchemcomm"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1016\/j.tetlet.2013.07.126","article-title":"Cu-mediated 1, 3-dipolar cycloaddition of azomethine ylides with dipolarophiles: A faster access to spirooxindoles of potential pharmacological interest","volume":"54","author":"Singh","year":"2013","journal-title":"Tetrahedron Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejmech.2016.04.025","article-title":"Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3\u2032-methoxy-4\u2032-(2-amino-2-oxoethoxy)-benzylidene) indolin-2-ones as potential antitumour agents","volume":"118","author":"Senwar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.ejmech.2018.06.061","article-title":"Design, synthesis, antiproliferative activity, molecular docking and cell cycle analysis of some novel (morpholinosulfonyl) isatins with potential EGFR inhibitory activity","volume":"156","author":"Ammar","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"112214","DOI":"10.1016\/j.ejmech.2020.112214","article-title":"Discovery of aryl-piperidine derivatives as potential antipsychotic agents using molecular hybridization strategy","volume":"193","author":"Zhu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s11224-020-01497-w","article-title":"Isatin derivatives as DNA minor groove-binding agents: A structural and theoretical study","volume":"31","author":"Santiago","year":"2020","journal-title":"Struct. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1021\/acsomega.1c05801","article-title":"In Vitro Antimicrobial Evaluation, Single-Point Resistance Study, and Radiosterilization of Novel Pyrazole Incorporating Thiazol-4-one\/Thiophene Derivatives as Dual DNA Gyrase and DHFR Inhibitors against MDR Pathogens","volume":"7","author":"Ammar","year":"2022","journal-title":"ACS omega"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/fft2.44","article-title":"Guidelines for cell viability assays","volume":"1","author":"Kamiloglu","year":"2020","journal-title":"Food Front."},{"key":"ref_29","first-page":"1","article-title":"425: Acute Oral Toxicity: Up-and-Down Procedure","volume":"4","author":"Oecd","year":"2008","journal-title":"OECD Guidel. Test. Chem. Sect."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.2147\/IJN.S86467","article-title":"Combination of glycosphingosomes and liposomal doxorubicin shows increased activity against dimethyl-\u03b1-benzanthracene-induced fibrosarcoma in mice","volume":"10","author":"Khan","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.etap.2013.07.016","article-title":"Ethanolic extract of Boswellia ovalifoliolata bark and leaf attenuates doxorubicin-induced cardiotoxicity in mice","volume":"36","author":"Mahesh","year":"2013","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_32","unstructured":"Akhila, J.S., Shyamjith, D., and Alwar, M.C. (2007). Acute toxicity studies and determination of median lethal dose. Curr. Sci., 917\u2013920."},{"key":"ref_33","unstructured":"Suvarna, K.S., Layton, C., and Bancroft, J.D. (2018). Bancroft\u2019s theory and practice of histological techniques E-Book, Elsevier Health Sciences."},{"key":"ref_34","unstructured":"Culling, C.F.A. (2013). Handbook of Histopathological and Histochemical Techniques: Including Museum Techniques, Butterworth-Heinemann."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/ATVBAHA.113.301585","article-title":"Insulin resistance is associated with significant clinical atherosclerosis in nondiabetic patients with acute myocardial infarction","volume":"33","author":"Karrowni","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/14756366.2017.1279155","article-title":"Synthesis and in vitro anti-proliferative activity of some novel isatins conjugated with quinazoline\/phthalazine hydrazines against triple-negative breast cancer MDA-MB-231 cells as apoptosis-inducing agents","volume":"32","author":"Eldehna","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"104133","DOI":"10.1016\/j.bioorg.2020.104133","article-title":"Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1, 2, 3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses","volume":"103","author":"Rezki","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_38","first-page":"61","article-title":"Progestin type affects the increase of heparanase level and procoagulant activity mediated by the estrogen receptor","volume":"36","author":"Treger","year":"2021","journal-title":"Hum. Reprod."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejmech.2013.09.005","article-title":"Anticancer evaluation of some newly synthesized N-nicotinonitrile derivative","volume":"69","author":"Shamroukh","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"130317","DOI":"10.1016\/j.molstruc.2021.130317","article-title":"Design, synthesis, antiproliferative evaluation, and molecular docking study of new quinoxaline derivatives as apoptotic inducers and EGFR inhibitors","volume":"1236","author":"Fayed","year":"2021","journal-title":"J. Mol. Struct."},{"key":"ref_41","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J. Lab. Clin. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7370157","DOI":"10.1155\/2020\/7370157","article-title":"Elevated glutathione peroxidase 2 expression promotes cisplatin resistance in lung adenocarcinoma","volume":"2020","author":"Du","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-2275(20)37347-8","article-title":"Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures","volume":"22","author":"Gavino","year":"1981","journal-title":"J. Lipid Res."},{"key":"ref_44","first-page":"e61122","article-title":"Evaluation of Oxidative Stress in Biological Samples Using the Thiobarbituric Acid Reactive Substances Assay","volume":"159","author":"Borges","year":"2020","journal-title":"JoVE J. Vis. Exp."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bioorg.2019.01.016","article-title":"Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers","volume":"85","author":"Ammar","year":"2019","journal-title":"Bioorg. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5694","DOI":"10.1002\/chem.202000252","article-title":"Visible-Light-Mediated Click Chemistry for Highly Regioselective Azide\u2013Alkyne Cycloaddition by a Photoredox Electron-Transfer Strategy","volume":"26","author":"Wu","year":"2020","journal-title":"Chem. Eur. J."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"165715","DOI":"10.1016\/j.bbadis.2020.165715","article-title":"Cell cycle regulators in cancer cell metabolism","volume":"1866","author":"Fajas","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.20892\/j.issn.2095-3941.2017.0033","article-title":"Cell cycle regulation and anticancer drug discovery","volume":"14","author":"Bai","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jinorgbio.2018.02.014","article-title":"Nickel (II) bis (isatin thiosemicarbazone) complexes induced apoptosis through mitochondrial signaling pathway and G0\/G1 cell cycle arrest in IM-9 cells","volume":"182","author":"Balachandran","year":"2018","journal-title":"J. Inorg. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104366","DOI":"10.1016\/j.bioorg.2020.104366","article-title":"Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents","volume":"105","author":"Yousef","year":"2020","journal-title":"Bioorg. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1172\/JCI9054","article-title":"Anticancer drug targets: Cell cycle and checkpoint control","volume":"104","author":"Shapiro","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Pfeffer, C.M., and Singh, A.T.K. (2018). Apoptosis: A target for anticancer therapy. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020448"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.18632\/aging.100934","article-title":"Apoptosis as anticancer mechanism: Function and dysfunction of its modulators and targeted therapeutic strategies","volume":"8","author":"Pistritto","year":"2016","journal-title":"Aging"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Cao, L., Zhang, L., Zhao, X., and Zhang, Y. (2016). A hybrid chalcone combining the trimethoxyphenyl and isatinyl groups targets multiple oncogenic proteins and pathways in hepatocellular carcinoma cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161025"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00280-001-0376-4","article-title":"Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines","volume":"49","author":"Lee","year":"2002","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"36690","DOI":"10.1039\/C9RA07002H","article-title":"5-Acetamido-1-(methoxybenzyl) isatin inhibits tumor cell proliferation, migration, and angiogenesis","volume":"9","author":"Zhang","year":"2019","journal-title":"RSC Adv."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/med.21308","article-title":"Involvement of urokinase-type plasminogen activator system in cancer: An overview","volume":"34","author":"Mekkawy","year":"2014","journal-title":"Med. Res. Rev."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2018.00024","article-title":"Multifaceted role of the urokinase-type plasminogen activator (uPA) and its receptor (uPAR): Diagnostic, prognostic, and therapeutic applications","volume":"8","author":"Mahmood","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/156800912798888983","article-title":"Targeting urokinase and the transferrin receptor with novel, anti-mitotic N-alkylisatin cytotoxin conjugates causes selective cancer cell death and reduces tumor growth","volume":"12","author":"Vine","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1067\/msy.2002.125719","article-title":"Heparanase-1 expression is associated with the metastatic potential of breast cancer","volume":"132","author":"Maxhimer","year":"2002","journal-title":"Surgery"},{"key":"ref_61","first-page":"1299","article-title":"The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma","volume":"7","author":"Yamanoi","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Coombe, D.R., and Gandhi, N.S. (2019). Heparanase: A challenging cancer drug target. Front. Oncol., 1316.","DOI":"10.3389\/fonc.2019.01316"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02624-1","article-title":"Heparanase and the hallmarks of cancer","volume":"18","author":"Jayatilleke","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.tibs.2014.03.001","article-title":"Heparan sulfate signaling in cancer","volume":"39","author":"Knelson","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_66","first-page":"1850","article-title":"Heparanase released from mesenchymal stem cells activates integrin beta1\/HIF-2alpha\/Flk-1 signaling and promotes endothelial cell migration and angiogenesis","volume":"33","author":"Hu","year":"2015","journal-title":"Stem Cells"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/3\/722\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:39:59Z","timestamp":1760135999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/3\/722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,20]]},"references-count":66,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["biomedicines10030722"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10030722","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,20]]}}}